This population-based study suggests that several initial cancers are associated with elevated risk of CCA, and the increased risk may be due to shared genetic or environmental etiological factors between these malignancies.
A clinical model incorporating age (≥65 years), T stage (T3/T4), N stage (N2/N3), and chemotherapy (no) was developed to predict inferior OS in early-stage MedBC.
Y. Tan, X. Tian, Q. Li et al.· Hong Kong medical journal =...· 0 citations
American Joint Committee on Cancer PS offers superior prognostic stratification compared to UICC AS in high-risk luminal breast cancer, and incorporation into clinical practice may enable more personalized treatment approaches, particularly when identifying candidates for adjuvant abemaciclib therapy.
An internally validated prediction model for BrM in GI cancers developed and validated performance in a held-out cohort to develop a clinically interpretable prediction model.
M. V. Barcelona, K. Kataki, F. A. Rahman et al.· British Journal of Cancer· 0 citations
This simple, validated model effectively stratifies short-term PC risk using routine data, potentially facilitating targeted surveillance in the general population.
Hyo Jeong Lee, Ji Seon Oh, Sehee Kim et al.· Diagnostics· 0 citations
The risk of CRC varied across first primary cancer sites but remained elevated among both short- and long-term survivors, demonstrating the importance of improving adherence to CRC screening guidelines among cancer survivors.
Dylan E. O'Sullivan, R. Hilsden, Hannah Harsanyi et al.· International Journal of Can...· 0 citations
Young-onset bladder cancer survivors experience a sustained elevation in second primary malignancy risk, underscoring the importance of long-term survivorship awareness and informing counseling and follow-up strategies in this population.
E. Eigner, N. Fazaa, A. Nsair et al.· International Journal of Cli...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
